Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.33 USD
Change Today 0.00 / 0.00%
Volume 0.0
UNISZ On Other Exchanges
Symbol
Exchange
NASDAQ GM
OTC US
Stuttgart
Berlin
As of 8:10 PM 07/13/15 All times are local (Market data is delayed by at least 15 minutes).

unilife corp-cdi (UNISZ) Key Developments

Unilife Corporation - Special Call

To update shareholders on its business activities and introduce the Imperium™ platform of instant insulin patch pumps

Unilife Corporation Announces Introduction of Imperium™ Platform of Instant Patch Pumps for Insulin

Unilife Corporation announced the introduction of the Imperium™ platform of instant patch pumps for insulin. Imperium is a prefilled, disposable, multi-day wearable insulin pump that does not require filling or assembly by the patient. Because it is prefilled and pre-assembled like an insulin pen, only three intuitive steps are required to commence continuous subcutaneous insulin infusion, with on-demand bolus delivery available to the user via the simple push of a button. Imperium can include wireless connectivity systems, such as Bluetooth LE, to integrate with smartphone apps for patient reminders and status updates. With data connectivity available, healthcare providers could also have access to real-time or historic data to tailor the insulin therapy for each patient to achieve and maintain glycemic control. Imperium is designed for supply to a select insulin partner or partners ready for filling and packaging using standard pharmaceutical processes, materials and equipment. Insulin partners can then sell the prefilled, fully-assembled device through existing commercial channels, with no sales, marketing, commercial development, reimbursement, and clinical support costs to Unilife. As a prefilled, high-precision device with a delivery resolution of 0.5µL, Imperium is suitable for use with high concentration insulins up to U-500.

Unilife Corporation Mulls Acquisitions

Unilife Corporation (ASX:UNS) is seeking acquisitions. Unilife Corporation has signed an equity purchase agreement for up to AUD 45 million with Lincoln Park Capital Fund, LLC which provides the company with AUD 5 million in initial net proceeds and the option to generate, at its sole control and discretion, up to AUD 40 million in additional net proceeds over 24 months. Unilife Corporation said, “The Company intends to use the net proceeds received from the financing with Lincoln Park Capital Fund, LLC and the at-the-market facility for investments in its plant, equipment, systems and personnel to further develop its manufacturing and operational capabilities to satisfy current and future customer orders and general corporate purposes, including working capital, acquisitions and other business opportunities.”

Unilife Corporation Amends Debt Financing Agreement with Orbimed

Unilife Corporation said that it has amended its debt agreement with OrbiMed as of 30 June 2015. Under the amendment, OrbiMed has removed a covenant that required Unilife to generate at least USD 20 million in cash receipts from customers during the six months ended 30 June 2015. There were no other adjustments to any of the terms of the debt agreement as part of this amendment.

Unilife Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 03:00 PM

Unilife Corporation Presents at Jefferies 2015 Global Healthcare Conference, Jun-01-2015 03:00 PM. Venue: The Grand Hyatt Hotel, New York, New York, United States. Speakers: Alan D. Shortall, Chairman, Chief Executive Officer, Member of Strategic Partnerships Committee and Chief Executive Officer of UMSL.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UNISZ:US $0.33 USD 0.00

UNISZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Becton Dickinson and Co $152.15 USD +0.15
West Pharmaceutical Services Inc $59.87 USD +0.09
Ypsomed Holding AG SFr.107.20 CHF +0.20
View Industry Companies
 

Industry Analysis

UNISZ

Industry Average

Valuation UNISZ Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNILIFE CORP-CDI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.